Home > Authors and editors

Antonio Cardi

San Giovanni Addolorato Hospital, Rome

Antonio Cardi is a surgeon with a degree in medicine and surgery from the University of Rome \"La Sapienza,\" Italy, where he graduated with a 110 cum laude distinction and was a winner of the Specialization Competition in Urology. Dr. Cardi obtained a specialization diploma in urology with honors, and his research activities include laparoscopic urological surgery. He holds a Ph.D. in New Technologies in Surgery and has been involved in numerous research activities, presenting abstracts at various congresses and conferences. Throughout his career, Dr. Cardi has worked in different hospitals and institutions, gaining valuable experience in laparoscopic surgeries, robotic surgery, and urological oncology. He currently works at the Urology Unit of San Giovanni Addolorata, Rome, Italy, specializing in robotic surgery and other advanced urological procedures. Dr. Cardi\'s contributions to the field have been remarkable, having performed more than 300 major robotic surgeries as the primary surgeon.

1chapters authored

Chapters authored

Quality of Life in Neurogenic Bladder Patients and Improvement after Botulinum Toxin Injection

By Giovanni Palleschi and Antonio Cardi

Various neurogenic conditions may determine an altered function of the bladder and urethral sphincters leading to urinary symptoms. Among these symptoms, loss of urine is considered the most bothersome, and recent literature has proposed that urinary incontinence and poor quality of life should be considered as associated conditions. Urinary incontinence is responsible for reducing the enjoyment of life, including loss of self-confidence and limitation of social activity; it is also associated with anxiety, depression, and deterioration in sexual life, and reduced physical activity. Conservative treatments represent a first-line therapeutic approach to neurogenic urinary disorders, followed by oral medications. However, these treatments often do not provide complete recovery from symptoms, especially from urinary incontinence. Onabotulimun toxin A has proven to be safe and effective for treating neurogenic urinary incontinence and its use is associated with a strong improvement of patients’ quality of life. Furthermore, this treatment lowers the risk of severe complications to the upper urinary tract, reducing the need for hospitalization. Quality of life improvement as well as clinical efficacy must be considered targets of the therapy, and the use of onabotulimun toxin A for treating neurogenic urinary incontinence reaches both these goals.

Part of the book: Botulinum Toxin

Related collaborators

Ali Abdel Raheem

Tanta University , Egypt

Anna V. Reznik

Mohamed H. Zahran

Giovanni Palleschi

NEFROCENTER, Medica San Carlo, Frascati (Rome, Italy)

Imad Katbeh

Ibrahim Alowidah

King Saud Medical City , Saudi Arabia

Diaa-Eldin Taha

Kafrelsheikh University , Egypt

Mohammad Osama Makkeiah

Damascus University , Syria

Tamara Kosyreva

Peoples' Friendship University of Russia , Russia

Lada Saneeva

Peoples' Friendship University of Russia , Russia